Drug intelligence / Profile preview

shufeng zhike formula

Development stage: Preclinical
Lead developer: Panyu Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Shufeng Zhike Formula is a Traditional Chinese Medicine (TCM) herbal preparation developed by the Guangzhou Panyu Hospital of Chinese Medicine. It is primarily used for the treatment of cough variant asthma (CVA), specifically targeting the 'Wind-Cold Invading Lung' syndrome. The formula is designed to alleviate chronic cough by dispelling pathogenic wind and cold, which are believed in TCM to trigger airway hyperresponsiveness. Clinical evaluation of the formula focuses on its ability to improve symptoms, reduce the need for rescue medication, and modulate inflammatory pathways associated with asthma. It is typically administered as an oral decoction.

Other names: Shufeng Zhike FangShufeng Zhike decoction

Beyond the preview

Go deeper on shufeng zhike formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on shufeng zhike formula.

Explore the full profile